San Diego, CA, United States of America

Daniel A Norris


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 114(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Daniel A. Norris

Introduction

Daniel A. Norris is a prominent inventor based in San Diego, California, known for his significant contributions to the field of pharmacokinetics and drug design. With a total of three patents to his name, he is recognized for developing innovative methods that enhance the efficiency and effectiveness of compound screenings and drug formulations.

Latest Patents

Norris's groundbreaking patents include:

1. **Method for Screening and Producing Compound Libraries**

This invention provides a secondary compound library produced by screening a primary compound library through an absorption-based method. The screening involves generating an in vivo absorption profile from initial dose data and in vitro bioavailability data, including permeability and solubility aspects. This method facilitates the identification of compounds with desired absorption profiles, thereby enhancing the drug design process.

2. **Pharmacokinetic-Based Drug Design Tool and Method**

This patent outlines a PK tool designed for predicting the absorption of administered compounds. The tool employs a physiologic-based simulation model that takes into account various physiological barriers to absorption based on the administration route. The tool's computer-readable components include an input/output system, simulation engine, and methods for optimizing the simulation model. The PK tool enables the selection and design of drugs, screens compound libraries, and predicts drug efficacy using in vitro and in vivo data.

Career Highlights

Daniel A. Norris is associated with Lion Bioscience AG, where his innovative research continues to impact drug development and pharmacology. His work enhances the understanding of compound absorption and the effectiveness of drug formulations.

Collaborations

Throughout his career, Norris has collaborated with talented individuals such as George M. Grass and Glen D. Leesman. These partnerships further streamline the innovative processes at Lion Bioscience AG and contribute to the success of complex pharmacological projects.

Conclusion

Daniel A. Norris is a remarkable inventor whose contributions to pharmacokinetics and drug design exemplify innovation in the biotechnology sector. With his patents, he continues to push the boundaries of traditional drug development methods, paving the way for more effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…